U.S. Construction Stock News

NYSE:STUB
NYSE:STUBEntertainment

StubHub (STUB) Stock Drops As Profit Rebound Meets World Cup Doubts

StubHub Holdings stock dropped about 10% to US$7.68 in Thursday trading, which makes it look like the market hated this quarter. The headline story is more complicated. The ticketing marketplace just printed Q2 revenue of US$573.1m and net income of US$29.3m, with adjusted earnings before interest, tax, depreciation and amortization nearly doubling to about US$106m on an 18% margin. That mix of sharp share price fall and clear profitability improvement is the gap investors now have to...
NasdaqGS:HLIT
NasdaqGS:HLITCommunications

Harmonic (HLIT) Stock Jumps As Profit Strength Validates Broadband Growth

Harmonic has been trading like a growth story in waiting, and today the stock finally traded that way. Shares jumped about 9% to US$13.09 after the broadband software company delivered Q2 numbers that pointed straight at earnings power, not just promises. The headline is profit quality. Broadband revenue hit US$133.5m and Q2 earnings per share came in at US$0.21, ahead of guidance, with operating profit at US$31.3m. For a stock already on a rich 54x P/E, that kind of delivery is what bulls...
NasdaqGS:SEER
NasdaqGS:SEERLife Sciences

Seer (SEER) Stock Faces Revenue Slump As Losses Stay Heavy

Seer came into this earnings print as a high‑expectation growth stock in proteomics, with the share price up over the past quarter and trading on a rich P/S multiple. The immediate reaction was muted, with the stock slipping about 2% to US$2.10. That small move sits against a quarter that again showed modest revenue of US$3.1 million and a net loss of US$16.9 million, while cash and investments held at US$209.5 million. The key focus for Seer this quarter is the ongoing profitability strain...
NasdaqGS:TECH
NasdaqGS:TECHLife Sciences

Bio-Techne (TECH) Stock Stalls As 61.8x P E Meets Soft Demand

Bio-Techne walked into this earnings print with a high bar and an equally high price tag. The stock trades on a trailing P/E of about 61.8x, yet the immediate reaction was a flat shrug, with the share price slipping just 0.1% to about US$72. That tiny move hides a much bigger story. Over the last year, earnings from continuing operations climbed to US$181.9 million on revenue of about US$1.2b, and net profit margins sat at 15%. The market now needs to decide whether that margin profile...
NasdaqGS:GLNG
NasdaqGS:GLNGOil and Gas

Golar LNG (GLNG) Stock Faces Valuation Doubts Despite Strong Backlog

Golar LNG stock barely budged after earnings, up just 0.3% to US$51.22, even though the company reported another strong quarter. The market treated the release as business as usual. The results told a different story for a capital intensive liquefied natural gas infrastructure company that relies heavily on contracted cash flows. The main focus this quarter is earnings power. Quarterly net income of US$56m was supported by about US$127m in earnings before interest, tax, depreciation and...
NasdaqGS:OCTV
NasdaqGS:OCTVSoftware

Octave Intelligence (OCTV) Stock Shrugs Off $2b Loss As Growth Stalls

Octave Intelligence stock barely flinched after earnings, slipping about 1% to US$18.88, even as the income statement delivered a shock. The company booked a Q2 loss of roughly US$2.0b, driven by sizeable goodwill and brand impairments that turned an otherwise cash generative software business into a headline loss story overnight. The market seems to be shrugging at that profit squeeze and focusing instead on recurring revenue power and margins. Annual recurring revenue sits at US$1.143b and...
NasdaqGS:ALHC
NasdaqGS:ALHCHealthcare

Is Alignment Healthcare (ALHC) Undervalued Following Whistleblower Claims And Accounting Investigations?

Alignment Healthcare (ALHC) is under scrutiny after a whistleblower accused the company of inflating financial results by classifying operating expenses as capital expenditures. This has triggered multiple law firm investigations and a sharp stock reaction. See our latest analysis for Alignment Healthcare. At a share price of $13.46, Alignment Healthcare has seen its 30 day share price return fall 36.51% and its year to date share price return decline 33.43%. However, the 3 year total...
NYSEAM:TGEN
NYSEAM:TGENBuilding

Tecogen (TGEN) Stock Climbs Despite Deeper Losses And Unproven Data Center Demand

Tecogen stock closed at US$4.19 today, up 4.5%, which is a firm move for a company that still reported a wider quarterly loss. The headline is not about revenue for this on site power and cooling player. It is about a growing loss that reached US$2.1m in Q2 on US$5.7m of sales and a trailing twelve month loss of US$10.4m. Short term traders are reacting to the bounce and the data center story. Long term holders are likely focused on whether that loss profile can be contained over time. Love...
NasdaqGS:TRMB
NasdaqGS:TRMBSoftware

Trimble (TRMB) Stock Tracks Margin Gains Despite Heavy Quarterly Loss

Trimble walked into this earnings print with a stock that has drifted over the past week but climbed about 11.5% over the last month. The immediate reaction is calm confidence rather than euphoria. The share price moved only 2.1% higher to about $57.55, even though the headline is aggressive cost and profit execution. The real story is margins. Trimble delivered a Q2 EBITDA margin of 28.6% and now talks about reaching roughly 30% for 2026, a year earlier than previously targeted. For a...
NasdaqGS:ENVX
NasdaqGS:ENVXElectrical

Enovix (ENVX) Stock Drops As Cash Strength Meets Execution Delays

Enovix stock dropped about 6% today to US$4.43, even though the headline numbers looked more like a check in than a collapse. Q2 revenue came in at US$9 million and the company reported a loss of US$43.1 million. What really grabbed attention was the cash position, with roughly US$552 million on hand. Short term traders focused on the red on the screen. Longer term investors will be weighing that cash runway and early gross profit against the still heavy operating losses and the rich sales...
NYSE:ETR
NYSE:ETRElectric Utilities

Entergy Stock And the Utility Names Tied to Rising US Power Demand

Relentless U.S. heat waves are no longer just a weather story. They are starting to show up in GDP estimates, business closures and power bills, while electricity demand from air conditioning and energy hungry data centers keeps climbing. That mix creates real risks and potential openings for investors. This article walks through three U.S. utilities and power infrastructure stocks exposed to these trends so you can decide how, or if, they fit your watchlist. The stocks covered below are just...
NYSE:WWW
NYSE:WWWLuxury

Wolverine World Wide (WWW) Stock Jumps On Profit Resilience And Margin Strength

Wolverine World Wide stock jumped about 10% today, a sharp move for a footwear and apparel company that has already climbed over the past quarter. The market is reacting to a clean earnings headline. Revenue in Q2 reached about US$506 million and adjusted earnings per share came in around US$0.40. The focus is on margin quality. Gross margin held in the mid 40s while adjusted operating margin sat near 10%, even with tariff pressure and higher freight. Today’s move appears to reflect investors...
NYSE:KMT
NYSE:KMTMachinery

Kennametal (KMT) Stock Eyes Margin Durability As Cash Flow Tightens

Kennametal stock slipped 1.3% to US$30.38 today, even after the company posted one of its strongest earnings years in recent memory. The market focused on a weak tape and short term free cash flow pressure. The story over the next few years hinges on whether investors trust the profit engine that produced US$4.49 in trailing earnings per share and a 14.5% net margin. For a metal cutting tools manufacturer tied to industrial and aerospace cycles, that kind of margin step change is the key...
NYSE:BORR
NYSE:BORREnergy Services

Borr Drilling (BORR) Stock Can Backlog Growth Outrun A Deepening Loss?

Borr Drilling came into this print looking like a classic high beta recovery stock that had stalled. The share price is down about 36% over the past three months, and it slipped another 1.7% today to close at US$4.04, even as many investors still point to a low P/S multiple and bullish long range forecasts. The headline this quarter is not revenue or rig utilization. It is the sharp hit to profitability, with Q2 2026 net loss widening to US$241.4m and adjusted EBITDA down to US$43.8m as one...
NasdaqGS:AOSL
NasdaqGS:AOSLSemiconductor

Alpha And Omega Semiconductor (AOSL) Stock Sinks As Losses Cloud AI Progress

Alpha and Omega Semiconductor came into this print with a bruised chart and a value label, and the market just hit it again. The stock dropped about 15% to US$30.75 after the report, even though the headline was not a collapse in demand. Revenue in the June quarter landed at US$170.4m and non GAAP gross margin reached 23.7%. The main issue is the pressure from ongoing losses and higher operating spend in a sector where investors tend to focus on clean earnings and cash generation. Love the...
NasdaqGS:LITE
NasdaqGS:LITECommunications

Lumentum (LITE) Stock Sinks As Non Cash Loss Masks AI Margin Strength

Lumentum Holdings came into this print priced for perfection, with the stock up over the past month and trading on a rich sales multiple, yet the shares dropped about 6% today. The market focused on the headline loss from a very large non cash charge tied to convertible note conversions and sold first. The core story looks very different. Quarterly revenue reached about US$1.01b and non generally accepted accounting principles operating margin landed at 36.6%, while non generally accepted...
NYSE:KTB
NYSE:KTBLuxury

Kontoor Brands (KTB) Stock Jumps On Buyback Push Despite Revenue Slide

Kontoor Brands stock was not priced for drama coming into this earnings season. The shares were up 36.1% over the past three months and then tacked on another 3% today to about US$84 as investors cheered a cleaner, more profitable story. The headline is simple. Kontoor Brands delivered a Q2 that reinforced its premium label status with about US$584.3m of revenue and earnings power that management feels confident enough to back with higher profit guidance, a US$400m accelerated share...
NasdaqGS:XRAY
NasdaqGS:XRAYMedical Equipment

Is DENTSPLY SIRONA’s (XRAY) Steady Buyback and Reaffirmed Outlook Reframing Its Risk‑Reward Profile?

DENTSPLY SIRONA Inc. reported past second-quarter 2026 results showing sales of US$898 million, up from a net loss to net income of US$37 million, while reaffirming full-year 2026 net sales guidance of US$3.5 billion to US$3.6 billion. Alongside this mix of lower year-on-year revenue and improved profitability, the company continued its long-running buyback, repurchasing 1,300,000 shares for US$12.92 million in the latest quarter. We’ll now examine how reaffirmed full-year sales guidance...
NasdaqGS:WING
NasdaqGS:WINGHospitality

Does Wingstop’s Board Expansion and Flavor Rodeo Revival Reveal a Deeper Brand Strategy for WING?

Wingstop recently boosted its board to eleven members by appointing PENN Entertainment CEO Jay Snowden as an independent Class II director, while also expanding its Flavor Rodeo promotion with returning fan-favorite sauces, new limited-time items, and exclusive Club Wingstop access in the US. This combination of leadership reinforcement and high-profile flavor innovation underscores Wingstop’s emphasis on governance depth alongside marketing that strengthens customer loyalty and brand...
NasdaqGS:KLIC
NasdaqGS:KLICSemiconductor

Kulicke and Soffa Industries (KLIC) Is Up 5.7% After Return To Profitability And Buyback Completion

Kulicke and Soffa Industries recently reported third-quarter 2026 results showing sales of US$330.41 million and net income of US$57.42 million, alongside issuing fourth-quarter guidance for approximately US$375 million in revenue and GAAP diluted EPS of about US$1.29. These results marked a shift from losses a year earlier and were accompanied by the completion of a multi-year US$73.53 million share repurchase program covering 1,962,177 shares. With this return to profitability and...
NYSE:ARCO
NYSE:ARCOHospitality

Arcos Dorados Holdings (ARCO) Stock Still Looks Undervalued After A 73% Return

Arcos Dorados Holdings has delivered a 73.0% return over the past five years, yet current valuation checks and an intrinsic value estimate using a Discounted Cash Flow (DCF) approach both suggest the stock may still be pricing in a discount to its underlying cash flow potential. The 73.0% five year return shows Arcos Dorados Holdings has already rewarded patient shareholders, which raises the question of how much value is left on the table. Future cash flow growth from its McDonald’s...
NasdaqGS:MRX
NasdaqGS:MRXCapital Markets

Marex (MRX) Stock Draws Fresh Focus After 64% Earnings Jump

Marex Group stock edged up about 2% today, yet the real action sat in the income statement. Q2 revenue reached US$696m and adjusted profit before tax hit US$166m, with an adjusted PBT margin close to 24%. For a capital markets broker, that margin profile is the headline. It indicates that this is not purely a volume-focused story. It is a business turning trading flows and clearing balances into substantial profitability. Short term traders saw a green day. Long term investors saw a firm that...
NYSE:REZI
NYSE:REZIBuilding

Resideo Technologies (REZI) Stock Price Cracks As Record Quarter Fails To Convince

Resideo Technologies just took a 20% hit in a single session, with the stock closing at US$20.46 after sitting above US$25 yesterday. That is a brutal reset for a building technologies business that had already been sliding over the past month. The short term story is all pain. The headline from the earnings is different. Resideo delivered a record quarter with revenue around US$2.0b and adjusted earnings per share of US$0.83. Management is now guiding the stand alone Products & Solutions...
NYSE:NUVB
NYSE:NUVBPharmaceuticals

Nuvation Bio (NUVB) Could Be 69% Undervalued On Earnings And IBTROZI Data Focus

Nuvation Bio (NUVB) is in focus after second quarter 2026 results showed revenue of US$31.69 million and a net loss of US$62.84 million, as well as upcoming IBTROZI trial data presentations. See our latest analysis for Nuvation Bio. The share price sits at US$6.10 after a 1 day share price return that declined 4.98%. However, a 90 day share price return of 41.20% and a 1 year total shareholder return of 121.01% suggest momentum has been building around Nuvation Bio, as revenue trends and...